Arseus realises turnover growth of 8.8%

Fagron and Corilus achieve strong growth

Management reiterates expectations for 2010

Waregem (Belgium) / Rotterdam (the Netherlands)[1], 15 October 2010 – The consolidated turnover of Arseus increased 8.8% to € 94.9 million in the third quarter. Organic growth was 2.9%. In the first nine months of 2010, the consolidated turnover increased 8.0% to € 299.6 million. Organic growth was 2.8%.

Ger van Jeveren, CEO of Arseus: “We are very pleased with the developments in the third quarter. All divisions contributed to the turnover growth of 8.8%, 2.9% of which was organic. The strong development in turnover at Fagron and Corilus continued unabated. Despite the restructuring, Arseus Dental saw modest growth and Arseus Medical is once again building its strength, thanks to the strategic repositioning of its product offering.

With our unique combination of activities in professional healthcare, our strong market positions and our healthy financial situation, we are ideally positioned to proceed with the further implementation of our strategy. We are confident about the future and we confirm our earlier expectations for 2010 as a whole.”

The evolution of turnover per division is as follows[2]:

(x 1,000 euros) Q3 2010 Q3 2009 Evolutie Organische groei Fagron 40,245 34,293 +17.4% +5.0% Arseus Dental 35,113 34,763 +1.0% +1.0% Arseus Medical 12,018 11,724 +2.5% -5.1% Corilus 7,502 6,454 +16.2% +16.2% Total 94,877 87,234 +8.8% +2.9% (x 1,000 euros) 9M 2010 9M 2009 Evolutie Organische groei Fagron 125,320 107,635 +16.4% +7.3% Arseus Dental 114,810 114,349 +0.4% -0.2% Arseus Medical 37,140 34,881 +6.5% -5.0% Corilus 22,285 20,542 +8.5% +8.5% Total 299,555 277,407 +8.0% +2.8%

---